ERBB2 and neoplasm: This study found that the pCR rate reached 35% similar to our results, however in terms of tumor grade, and tumor biologic subtype, we didn’t find any of these factors were significant independent predictors of pCR, we considered this to be related to HER2 status, sample size, and selection bias, and statistical confirmation was needed at a later stage.